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Kinetic Assessment of Manganese Using
Magnetic Resonance Imaging in the Dually
Perfused Human Placenta In Vitro
by Richard K. Miller,* Donald R. Mattison,t Maurice
Panigel,* Toni Ceckler,* Robert Bryant,* and Peter
Thomfordt
The transferanddistribution ofparamagnetic manganese was investigated inthe duallyperfusedhuman
placenta in vitro (using 10, 20, 100 ,uM Mn with and without 5Mn) using magnetic resonance imaging
(MRI) and conventional radiochemical techniques. The human placenta concentrated 'Mn rapidly during
the first 15 min of perfusion and by 4 hr was four times greater than the concentrations of Mn in the
maternal perfusate, while theconcentration ofMn inthefetalperfusate was25%ofthe maternal perfusate
levels. Within placentae, 45% of the "Mn was free in the 100,000g supernatant, with 45% in the 1,000g
pellet. The magnetic fielddependence ofproton nuclearspin-lattice relaxation time (T1) in placental tissue
supports this Mn binding. Mn primarily affected the MRI partial saturation rather than spin-echo images
ofthe human placenta, which provided for the separation ofperfusate contributions from those produced
by Mn. The washout of the Mn from the placenta was slow compared with its uptake, as determined by
MRI. Thus, Mn was concentrated by the human placenta, but transfer of Mn across the placenta was
limited in either direction. These studies also illustrate the opportunity for studies of human placental
function using magnetic resonance imaging as a noninvasive biomarker.
Introduction
The movement of xenobiotic agents across the pla-
centa from mother to conceptus has been difficult to
assess in the human because of inaccessibility. Such
toxicokinetic assessments are essential for understand-
ing the effects ofagents on the developing organism as
well as the pregnant woman. Biomarkers ofeffect have
been the classical means for establishing damage to the
conceptus. It is hoped, however, that biomarkers of
exposure maybejust asimportantifnot moreimportant
to establishing populations that may or may not be at
risk for having abnormal pregnancies. Unfortunately,
to date, the assessment of maternal blood and urine
have been the primary fluids analyzed. More recently
amniotic fluid has also been screened. Yet, the kinetics
of practically all compounds is limited by the snapshot
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assessment for kinetic analysis at or about the time of
delivery, whensamplesofcordblood, placenta, amniotic
fluid, andfetalhairareeasilyobtained. Advancesintwo
different arenas have provided the opportunity to eval-
uate the characteristics ofhuman placental transfer for
different agents using a dually perfused human placen-
tal preparation in vitro and also using the noninvasive
technique ofmagnetic resonance imaging (MRI). These
techniques have been combined to determine the phar-
macokinetics and patterns ofdistributionwithinthe hu-
man placenta for the paramagnetic ion manganese.
Manganese can be neurotoxic in chronically exposed
miners (1-4). These men were affected by severe dis-
orders of speech, posture, and gait, as well as sexual
impotence. Mn is normally found in plasma from preg-
nant and nonpregnant women at levels of 1.5 to 2.0 ng/
mL (5). There are no reports concerning human expo-
sures to excess levels ofMn during pregnancy. A num-
ber of animal teratology studies using Mn during or-
ganogenesis have not shown malformations (two rat
studies, two hamsterstudies, one mouse study, and one
rabbit study) (4,6,7). In another earlier study by Ferm
(8), where the maternal lethal dose was 35 mg/kg, IV
MnCl2 produced a dose-related increase in resorptions,
butnomalformationswerereported. Behavioralstudies
in progeny exposed in utero have not been reported.MILLER ETAL.
A
FIGURE 1. Visualization ofMn in the pregnant cynomologus monkey. (A)Pregnant primate before injection ofMn. The image is a spin-echo
(TR = 600 msec; TE = 40 msec). Note that the anterior and posterior lobes ofthe placenta are poorly distinguished from the uterus. The
maternal kidney is observable. Continued on next page.
82KINETIC ASSESSMENT OF MANGANESE USING MRI IN HUMAN PLACENTA
B
FIGURE 1. Continued. (B) Pregnant primate from Fig. 1A, but 17 min afterinjection ofMn. Note the enhanced image ofthe placenta, which
is now separated from the uterine tissue and the fetus. The maternal kidney image is also enhanced. From Thomford et al. (23).
Certainly, Mn has the potential to be toxic to the de-
veloping CNS if sufficient Mn does reach the fetus.
The human investigations reported here are based
upon previous studies by Kay and Mattison (9) using
MRI in utero, where Mn was selectively concentrated
in the placenta of the rhesus monkey (Figs. 1A,B); in-
creases in Mn were not noted in the uterus or in the
fetus itself. Such selectivity in placental accumulation
with a minimal passage to the conceptus was proposed
as apossible tool forvisualizingthe placenta selectively
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using noninvasive techniques. It is hoped that by com-
bining MRI with in vitro human placental perfusion
studies, one may determine directly the kinetics and
possible toxicity of Mn by using sensitive methods for
analysis, e.g., radiochemical detection, and comparing
these data with the evaluation of manganese distribu-
tion via MR analysis.
Methods
In Vitro Human Placental Perfusion
Anextendeddualrecirculatinghumanplacentalprep-
aration was used in this study. The isolated human lob-
ular perfusion is based upon the original description by
Schneider, Panigel, and Dancis (10) as modified and
adaptedforextended perfusionbyMilleretal. (11). The
same physiological, morphological, and biochemical cri-
teria were used in these Mn studies as were previously
described (11). Major modifications of the perfusion
chamber and system were necessary to conform to the
dimensions of the magnetic resonance imaging equip-
ment as noted in Figures 2 and 3. Of special note is
approximately 12 feet oftubingrequired to connect the
chamberwiththefetalandmaternalpumps. Inaddition,
there are heating tubes in the perfusion chamber to
maintain the tissue at temperatures of 360C ± 1. The
internal diameter of the perfusion chamber was main-
tained; however, the height was reduced by 35%.
French 5umbilical catheters were used inboth the fetal
and maternal circulations. Flow rates were 15 mL/min
on the maternal side and 3 mL/min on the fetal side.
The fetal pressure was 34 ± 4 mm Hg.
The fetal perfusates were composed oftissue culture
medium M199 (Difco, Detroit, MI) with heparin (25 IU/
mL, A. H. Robbins), glucose (2.0g/L), dextran40(fetal:
30 g/L, maternal: 7.5 g/L, Sigma), and gentamicin (50
mg/L, A. H. Robbins). The fetal perfusate was gassed
with 95% N2/5% C02 and recirculated following the col-
lections of the first 40 mL of perfusate. The maternal
perfusate was gassed with 95% 02/5% C02 and also was
recirculated following the collection of the first 60 mL
ofperfusate. The recirculating volumes in the maternal
and fetal circuits were 190 and 65 mL, respectively.
Duringthe first 2 hr (the control period), two perfusate
sampleswerecollectedfromthefetalreservoirandfrom
the maternal arterial port every half hour for analysis
of Po2, Pco pH glucose, and lactate. At 2 hr, and
every 4 hrtiereafter, perfusates in both circuits were
exchanged for fresh perfusates. Sodium bicarbonate
was added to the perfusates when the pH was less than
7.32.
Fetalcapillaryintegritywasmonitored bymeasuring
the volume in the fetal reservoir during the perfusion.
The sensitivity ofthis method is + 2mL, which reflects
a measure of2 mL/hr as the limit ofdetection for leak
in these studies. Volume loss greater than 10 mL/hr
from the fetal circulation has been associated with an
inability ofthe capillaries to retain inulin and indicates
damage (12). Fetal arterial pressure was measured us-
ing a Grafco standard aneroid sphygmomanometer.
Blood gases and pH were measured using an Instru-
mentation Laboratories Model 1302 pH/blood gas ana-
lyzer. Maternal 02delivery, tissue 02consumption, and
net 02 transfer to the fetal circulation were calculated
according to the methods ofWier and Miller (13).
Manganese Assessments
In the first series of experiments, 5Mn plus MnCl2-
(10, 20, or 100 ,uM) was added together to either the
fetal or maternal reservoirs after a 2-hr control perfu-
MRI
MATERNAL CIRCUIT
PUMP
FETAL CIRCUIT
FIGURE 2. Schematic diagram of the perfusion apparatus at the MRI unit. MA = maternal artery; MV = maternal vein; FA = fetal artery;
FV = fetal vein.
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FIGURE 3. Perfusion chamber modified for MRI use. (A)Perfusion chamnber attached to "umbilical cord," which contains two maternal tubes,
two fetal tubes, and two heating tubes. Insulation material surrounds the three inflow tubes spanning the 12 feet from the pumps to the
MRI magnet (shown in 3B). All materials are constructed ofnonmagnetic materials, e.g., aluminum, teflon, plastic. Note heating coils in
bottom of chamber. (B)Perfusion chamber within the core of the 2.0 tesla General Electric MRI magnet at the University of Rochester's
Magnetic Resonance Imaging Facility.
85MILLER ETAL.
Table 1. Placental perfusate ratios for Mn.
Tissue perfusate
Perfusate, ratio, Rzmole/g/4imole/
Time,h-r ,umole/mL mL
Maternal administration
0.25 21.1 1.18
2.00 14.4 4.6 ± 0.05
4.00 8.5 3.9 ± 0.3
Fetal administration
2.00 9.4 4.2 ± 0.4
Table 2. Distribution of Mn within placental and fluid
compartments following in vitro perfusion.a
Administration % Mn in compartment
route Time, hr Maternal Placental Fetal
Maternal 2 350 56.0 8.5
Fetal 2 6.5 47.0 46.0
aAverage ofthree placental perfusions.
sion period. Perfusate samples (0.2 mL) were with-
drawn from the maternal artery, maternal vein, fetal
artery, and fetal vein simultaneously at 1 min intervals
for the first 20 min, then at 5 min intervals until 60 min.
After 60 mm following the addition ofthe Mn, samples
were collected every 15 min.
Mn was measured directly duringthe experiment via
anin-line MR probe (Praxis IIPulsed NuclearMagnetic
Resonance Analyzer, San Antonio, TX) in the maternal
artery for maternal additions ofMn or in the fetal vein
for fetal additions of Mn. The Praxis II is a 0.25 tesla
permanent magnet with the sample coil and a radio
frequency (RF) pulse generator operating at 10.7 MHz.
After the experiment, the other collections were meas-
ured in the Praxis. For MMn, samples were collected
from all four ports and analyzed via a Nuclear Chicago
gamma counter with a 48% efficiency for 5Mn.
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Magnetic Resonance Imaging of the Mn in
the Human Placenta
A mobile human placental perfusion unit was devel-
oped for use in the Magnetic Resonance Imaging Fa-
cilityattheUniversityofRochester. AGeneralElectric
2.0 tesla MRI unit was used with conventional spin-
echo spin warp imaging sequences to acquire the im-
ages. For tissue imaging with Mn, the optimized relax-
ation time (TR) was 500 msec, and the excitation time
(TE)was25msec. Studiesmaximizingfortissueimaging
without Mn had a TR of900 msec and a TE of75 msec.
Images were usually constructed from fourrepetitions.
Only imaging was performed on this unit. Studies were
conducted for periods of 15 min to 10 hr.
Morphological Assessment
At the end of the perfusion, chorionic villi were col-
lected in different regions ofthe perfused placental lob-
ule. These specimens were immediately fixed in
MacDowell's fixative and refrigerated until impregna-
tion and embedding in epoxy resin. Ultra thin sections
were examined with a Phillips electron microscope.
Results
The transfer and distribution of paramagnetic man-
ganese was investigated in 20 dually perfused human
placentae in vitro using magnetic resonance and con-
ventionalradiochemical techniques. Followingthebolus
injection ofMn into the maternal reservoir, the human
placental perfused lobule concentrated Mn rapidly dur-
ing the first 15 min of perfusion and by 4 hr was four
times greater than the concentrations ofMn in the ma-
ternalperfusate (Table 1). Similar concentrations ofMn
within the placenta were possible if Mn was presented
from the fetal circulation (Table 1).
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FIGURE 4. Placental perfusion of Mn as measured by '4Mn when added to the maternal circuit. The total length ofthis experiment was 6 hr,
where the first 2 hr were the control periods. The Mn was added following transfusion at 2 hr, and collections of fluids followed for an
additional 4 hr. Maternal arterial concentrations of Mn appeared at 9 min, while no peak was noted in the fetal vein for Mn.
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FIGURE 5. Placental perfusion of Mn as measured by 'Mn when added to the fetal circuit. The total length of this experiment was 4 hr,
where the first 2 hr were control. The Mn was added following transfusion at 2 hr, and collections offluids followed for an additional 2 hr.
Peak concentrations in the fetal artery for Mn occurred approximately 17 min after the addition ofthe Mn to the fetal circuit. During the
2 hr of perfusion, 7.4% of the total Mn transited to the maternal circulation; however, at 2 hr the concentration of Mn in the maternal
circuit was less than 10% ofthe fetal [Mn].
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FIGURE 6. Comparison ofradiochemical and MR spectrometric analyses ofMn under perfusion conditions in the human placental lobule. In
the upper graph, the radioactivity measurements were determined after the experiment was completed; in the lowergraph, a Praxis MR
unit with a modified flow cell directly measured the [Mn] in the maternal artery during the course ofthe experiment. The relaxation time
(T1) is known to be inversely related to the concentration ofMn as is apparent in this figure.
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Less than 10% ofthe total Mn is transferred in either
direction to the fetal or maternal compartments during
the first 2 hr of Mn exposure (Table 2). After 4 hr of
perfusion following addition ofMn to the maternal res-
ervoir, the concentration of Mn in the fetal perfusate
was 25% of the maternal perfusate levels as measured
via MMn (Fig. 4). Equilibration between the maternal
and fetal circuits did not occur following addition ofMn
to the fetal reservoir, even though the placenta did con-
centrate the Mn (Fig. 5). Addition of 100 ,umole/mL of
Mn to the maternal circuit did not saturate the amount
contained within the placenta or its percentage oftotal
Mn added to the maternal perfusate. Interestingly,
there was a smaller percentage of the Mn transferred
to the fetal compartment than noted for 10 or20 ,umole/
mL.
Within placentae, 45% of the 5Mn was free in the
cytosol, with the remainder being predominantly in the
10OOg pellet (43%) (Table 3). The MRI magnetic field
dependence ofwaterprotonrelaxation time (T1) is dom-
inated by the nonmanganese contributions at the con-
centrations used in these studies; however, a rise in
rate in the 20 MHz region supports the concept that a
significant fraction of Mn (II) ion is rotationally immo-
bilized orsamples alocal environment ofhigh viscosity.
The radiochemical and magnetic relaxation rates
were directly compared to determine the sensitivity of
analysis (Fig. 6). The relaxation rates in the maternal
arterial perfusates were proportional to the amount of
Mn as determined by 54Mn measurements in the same
experiment.
Mn primarily affected the MRI partial saturation
rather than spin-echo images of the human placenta.
The Mn enhanced the image intensity of the perfused
lobule, which is centrally located as expected for a man-
ganese-induced reduction ofT1 for this region (Fig. 7).
Note the peripheral tissues are low intensity, are not
perfused, and thus must be low in Mn concentration.
In the upper portion of Figure 7, which is an inverted
image ofFigure 3B, the low intensity circles represent
fluid flowing through the heating tubes. Similar low in-
tensity areas are noted for the fetal vasculature, since
fluids flowing through vessels appear dark upon MR
imaging. During washout ofthe Mn, the high intensity
ofthe placental lobule persisted for at least 4 hr, even
afterthematernaland fetalperfusates contained nearly
undetectable amounts ofMn. Thus, the Mn is not com-
pletely cleared from the placenta for extended periods,
Table 3. Cellular distribution of Mn in the human placenta
following maternal administration.
Cell fractiona % of total 54Mn
Nuclear 42.6 ± 3.5
Mitochondria 5.3 ± 1.1
Microsomes 2.4 ± 0.2
Supernatant 45.4 ± 4.2
Recovery 95.7
aNuclearfractionrepresents the 1OOOgpellet; mitochondriafraction
represents the lO,OOOg pellet; microsome fraction represents the
100,OOOg pellet; supernatant represents the 100,OOOg supernatant.
FIGURE 7. Cross-sectional viewofa duallyperfused human
placental lobule. The central, high intensity region is en-
hanced by the presence ofMn in the maternal perfusate.
The Mn is also concentrated in the placental tissue itself.
Note the darkerlateral tissue which is notbeingperfused
with the Mn. This image represents an inverted cross-
section of Fig. 3B, when a placenta would be present in
the chamber. The black circles in the top of the image
represent the heating coils in the amniotic fluid chamber
equivalent. This image was obtained via a General Elec-
tric 2.0 tesla MRI unit with a spin-echo spin warp se-
quence. The repetition rate was 500 msec and the echo
delay was set for25 msec. Dataacquistion used 256phase
encode steps, 1K data points using quadrative detection
per step. The image data were processed to a 512 x 512
matrix. The final pixel resolution was 120 mm/512.
which provides for an opportunity to perform repeated
scans ofthe tissue without havingto add additional Mn.
In the T2 weighted images, only the effect ofperfusion
withaperfusatecontainingminimalredbloodcellsdem-
onstratedanychangeintissueimage. Bothsetsofimage
acquistion parameters permitted visualization of vas-
culature; however, contrast between tissue and vessels
was better for the T1-weighted images (TR/TE, 500/25
msec) with Mn present.
Ultrastructural screeningofthe trophoblast and fetal
endothelium ofchorionic villi sampled at the end ofthe
4 and 2 hr ofdual perfusion demonstrated the integrity
of the constituents of the placental zone of maternal/
fetal exchange (Fig. 8A,C) as previously established for
human placental perfusions (14). In most areas of the
tissue examined, the trophoblast ultrastructure main-
tains a normal appearance ofthe cellularorganelles and
membranes (Fig. 8A). The fetal capillaries also keep
their normal ultrastructural aspect. Some ofthese cap-
illaries show red blood cells remaining in the perfusate.
The endothelial ultrastructure, as well as the neigh-
boring villus stromal constituents and trophoblastic
basement membrane, appear normal (Fig. 8C). In the
trophoblast covering of a few placental villi, however,
some changes in the microvilli, the endoplasmic retic-
ulum cisternae, and the mitochondria have been ob-
served (Fig. 8B). There were no alterations in glucose
utilization, lactate production, oxygen consumption, or
transfer or fetal volume loss during the course ofthese
kinetic studies. It is not yet possible to state without
further investigation if these ultrastructural changes
are duetothemorphologicalheterogeneityofthetroph-
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FIGURE 8. Electron micrographs ofperfused humanplacenta. (A)Syncytiotrophoblast coveringofaplacental villus after4hrofMn(20 ,umole/
mL), totalperfusion, 6hr. (B)Syncytiotrophoblast fromthesameplacentallobuleasinFig. 7A, butfromadifferentregion. Noteinvaginations
ofthe crypts and the less distinct limits ofthe mitochondria. (C)The constituents ofthe placenta maternal/fetal exchange region after 2 hr
of perfusion with manganese chloride (20 ,umole/mL), total perfusion, 4 hr. BM = basement membrane; CL = capillary lumen;
CR = microcrypt; CT = cytotrophoblast; ECJ = endothelialcelljunction; FE = fetalendothelium; FR = fetalredbloodcell; IVS = maternal
intervillous space; MI = mitochondria; MV = microvilli; S = stroma; ST = synctiotrophoblast.
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oblast covering of the placental villous tree or due, in
some areas, to a specific action of manganese on the
trophoblasticcytoarchitecture and organelles (Fig. 8C).
Discussion
These studies were undertaken for two primary rea-
sons: to determine the kinetics ofMn transfer into and
acrossthe humanplacentaand toestablishthepotential
for using MRI and paramagnetic ions forenhancingthe
visualization ofthe humanplacenta. Afewreports have
used MRI forexaminingpregnant women (15-21); how-
ever, these studies have primarily evaluated pregnan-
cies with suspected birth defects or other serious com-
promises. Functional studies have not been undertaken
in the human at this time in utero. There have been
other in vitro human tissue fragment studies with both
myometrium and trophoblast (22,23) as well as both in
vitro and invivo subhuman primate studies (9,23) using
MRI and Mn.
In utero, both for the human and the subhuman pri-
mate, ithasbeendifficulttoseparatetheadjacenttissue
(placenta and myometrium) because the MR relaxation
times (T1, spin-lattice and T2, spin-spin) are quite sim-
ilar. Thus, itbecomes difficult to separate maternal and
fetal tissue at this interface-the implantation site
(9,23). Previous invitro studies have alsodemonstrated
thathumanplacentalfragmentsdoconcentrate Mn. The
Mn in the tissue shortens the proton spin relaxation
times and enhances the contrast ofthe image. Relative
MnuptakecanbefollowedbyobservingchangesinMRI
contrast as more of the paramagnetic ion accumulates
inthetissue, asnotedinFigures 6and 7. Thus, dynamic
noninvasive measures of function (e.g., blood flow,
transport, and tissue concentration) can be achieved
withsequentialanalysis. Mnenhancesprotonrelaxation
in the perfused tissue making it possible to delineate
the perfused region. This enhancement of the tropho-
blast has been especially useful in visualizing the fetal
circulation, asmovingionsinfluids appearlowintensity
upon MRI. Thus, the tissue is high intensity and the
vessels are low intensity (studies in progress). Imaging
may allow for determining patterns of fetal circulation
in utero as is now possible in vitro.
The kinetics of Mn uptake by the placenta is quite
rapid, as noted in Table 2. This distribution among ma-
ternal and fetal circulations demonstrates that Mn is
not rapidly transferred to the opposite circuit, whether
added to the maternal or fetal perfusate. It should be
notedthatMnisprimarilylocalizedintheplacentaitself
(Table 3). Such concentration of Mn in the placenta is
certainly consistent with all previous investigations in
vitro with human tissue and with the monkey studies
inutero. These currenthumanstudies also areinagree-
ment with the monkey studies, demonstrating the lim-
itedtransferofMntothefetalcirculation. Thesestudies
with Mn are in contrast to gadolinium DPTA (Gd-
DPTA), which rapidly appears in the fetal circulation
and in the fetal bladder ofthe monkey (24).
Gd-DPTA is currently approved as a contrast agent
for MRI, while Mn is not approved because ofthe neu-
rotoxicity of Mn in the adult human following chronic
exposure and in neonatal animal studies (4). It would
be important to have neurotoxicity studies following
prenatal exposure to Mn in animals to determine
whetherMninsufficientquantitiesenterstheconceptus
and produces damage to the CNS. It is possible that
only at maternal toxic doses will Mn be toxic to the in
utero developing CNS. Future studies should evaluate
the kinetics of Mn bound to chelators, e.g., DPTA, to
determine the tissue enhancement characteristics as
well as toxicity phenomenon.
When Mn is compared to inulin, vitamin B12, and
cadmium under similar conditions, there is comparabil-
ity among the transfer of these compounds, which is
quite slow compared with antipyrine, amino acids, oxy-
gen, tritiated water, phenytoin or zinc (12,13,25-27).
With the exception ofinulin, Mn, vitamin B12, and cad-
mium are bound to placental proteins, and such binding
appearstoretardthemovementacrosstheplacentainto
the opposite circuit. Also, as noted for phenytoin and
tritiated water (26), manganese can be seen to move
from the perfused lobule radially or along septae into
nonperfused lobules. With time, nonperfused tissue
does accumulate these compounds depending upon
channeling and relative affinity of the tissue for the
compound.
Thus, Mnisconcentratedinthehumanplacentaunder
in vitro human placental perfusion conditions, whether
presented fromthematernalorfetalcircuit. Inaddition,
less than 10% ofthe total amount ofMn added appears
inthe opposite circuit. Suchuptake ofMnbythe human
placenta can be used selectively by MRI since Mn is a
paramagnetic ion. The placenta can be selectively im-
aged due to the concentration ofMn in the trophoblast.
For these acute studies no clearly identifiable signs of
toxic response have been determined. Perhaps longer
periods of exposure may be necessary to assess the
toxicity ofMninthehumanplacenta. Suchstudies dem-
onstrate the potential for MRI as a noninvasive tech-
nique for studying functional and structural changes
duringpregnancy, ashasbeenpreviouslydemonstrated
only at delivery (27) where tissue levels of metals, as
well as structural evaluations, have been performed.
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